Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of SENS-218 (Azasetron) in Healthy Caucasian Adults
NCT02772796Phase 1Completed
- Sponsor
- Simbec-Orion
- Start
- Feb 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of azasetron in inner ear disorder, sponsored by Simbec-Orion. Primary endpoints: Max plasma concentration, Time to Cmax and 6 more. Started Feb 2016; status: completed.
02
Drugs
azasetron
03
Conditions
inner ear disorder
Beyond the preview
Go deeper on NCT02772796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772796.